ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Imaging"

  • Abstract Number: 0472 • ACR Convergence 2024

    Impaired Cardiac Function in Contemporary Rheumatoid Arthritis Patients: A Comparative Pilot Study with Cardiovascular Magnetic Resonance-derived Strain Analysis

    Bas Dijkshoorn1, Sreen Mohamed2, Romy Hansildaar2, Henk Everaars3, Geoffrey Mooij3, Luuk Hopman3, Paul Knaapen3, Lourens Robbers3 and Michael Nurmohamed4, 1Amsterdam Rheumatology and immunology Center, Amsterdam, Netherlands, 2Amsterdam Rheumatology and Immunology center location Reade, Amsterdam, Netherlands, 3Department of Cardiology, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands, Amsterdam, Netherlands, 4Amsterdam University Medical Centers, Amsterdam, Netherlands

    Background/Purpose: Heart failure (HF) is an important, underdiagnosed comorbidity, with increased morbidity and mortality rates in rheumatoid arthritis (RA) patients. The risk of developing HF…
  • Abstract Number: 0862 • ACR Convergence 2024

    Two-year’s Worsening of Semi-quantitative MRI Features as Surrogate Outcomes for Long-term Incident Radiographic Knee Osteoarthritis After ACL-rupture

    Jos Runhaar1, Belle van Meer2, Vernon Smit1, mauro minnaard1, Edwin Oei1, Max Reijman1 and Duncan Meuffels1, 1Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands, 2St. Antonius Hospital Utrecht, Department of Sports Medicine, Utrecht, Netherlands

    Background/Purpose: With an annual incidence rate of 2-5% in high-risk populations, the use of established knee OA as an outcome challenges the feasibility of preventive…
  • Abstract Number: 1444 • ACR Convergence 2024

    Characterization and Comparison of MRI Findings in Axial Spondyloarthritis, Axial Psoriatic and Chronic Non-inflammatory Back Pain

    Mauricio Parada1, maría Luisa Molina1, Daniel Ríos1, Daniela Suarez1, Natalie Hitchin2, Cristóbal Bravo2, Nicolás Guzmán2 and Annelise Goecke1, 1Hospital Clínico Universidad de Chile, santiago, Chile, 2Universidad de Chile, Santiago, Chile

    Background/Purpose: MRI of the sacroiliac joints (SIJ) is part of the evaluation of patients with suspected axial spondyloarthritis (axSpA). However, sacroiliitis (SI) could be a…
  • Abstract Number: 1757 • ACR Convergence 2024

    Bimekizumab Treatment Resulted in Improvements in MRI Inflammatory and Structural Lesions in the Sacroiliac Joints of Patients with Axial Spondyloarthritis: 52-Week Results and Post Hoc Analyses from Two Phase 3 Studies

    Walter Maksymowych1, Sofia Ramiro2, Denis Poddubnyy3, Xenofon Baraliakos4, Robert Lambert1, Ute Massow5, Thomas Vaux6, Chetan Prajapati6, Alexander Marten5, Natasha de Peyrecave7 and Mikkel Ostergaard8, 1University of Alberta, Edmonton, AB, Canada, 2Leiden University Medical Center, Bunde, Netherlands, 3Charite-Universitatsmedizin Berlin, Berlin, Germany, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 5UCB Pharma, Monheim am Rhein, Germany, 6UCB Pharma, Slough, United Kingdom, 7UCB Pharma, Brussels, Belgium, 8Department of Clinical Medicine, University of Copenhagen and Center for Rheumatology, Copenhagen Center for Arthritis Research, Glostrup, Denmark

    Background/Purpose: The impact of bimekizumab (BKZ), a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)‑17F in addition to IL-17A, on structural lesions in patients (pts)…
  • Abstract Number: 2064 • ACR Convergence 2024

    Quantifying Cutaneous Dermatomyositis: A Novel 3D Image-based Approach

    Nantakarn Pongtarakulpanit1, Tanya Chandra1, shiri keret2, Eugenia Gkiaouraki3, Vladimir Liarski1, Dana Ascherman3, Siamak Mogahadam1, Chester Oddis1 and Rohit Aggarwal4, 1Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 2Rheumatology unit, Bnai-Zion medical center and the faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel., Atlit, Israel, 3Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA, 4Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA, Pittsburgh, PA

    Background/Purpose: Rapid advancement in image analysis now has a critical role in the diagnosis and assessment of skin lesions. The current standard of visual examination…
  • Abstract Number: 2685 • ACR Convergence 2024

    Association Between Gastrointestinal Bacterial Species and Radiological Features of Systemic Sclerosis-Interstitial Lung Disease (SSc-ILD): A Multicenter Study from the SSc Microbiome Consortium Project

    Arissa Young1, Kristofer Andreasson2, Swapna Joshi3, Jen Labus3, Andrea Low Hsiu Ling4, vanessa smith5, Zsuzsanna McMahan6, Antonia Valenzuela Vergara7, Susanna Proudman8, Grace Kim3, Gracijela Bozovic2, Jonathan Goldin3, Ezinne Aja3, Jonathan Jacobs3 and Elizabeth Volkmann9, 1UCLA, Los Angeles, CA, 2Lund University, Lund, Sweden, 3UCLA, Los Angeles, 43Singapore General Hospital, Duke-NUS, Singapore, Singapore, 5Ghent University Hospital, Gent, Belgium, 6UTHealth Houston Division of Rheumatology, Houston, TX, 7Pontificia Universidad Catolica de Chile, Santiago, Chile, 8Royal Adelaide Hospital, Adelaide, Australia, 9University of California, Department of Medicine, Los Angeles, CA, USA, Los Angeles

    Background/Purpose: Variations in gastrointestinal (GI) microbial communities may influence the development of lung diseases. Patients with SSc-ILD have a unique intestinal microbial signature. To further…
  • Abstract Number: L15 • ACR Convergence 2023

    AR882, an Efficacious and Selective URAT1 Inhibitor for Patients with Chronic Gouty Arthritis and Subcutaneous Tophi: Results from a Global, Prospective, Proof-of-Concept Trial Using Dual Energy Computed Tomography

    Robert Keenan1, James Cheng-Chung WEI2, Sarah Morris3, Pamella Mundell3, Wen Wei3, Ke Shi3, Zancong Shen3, Vijay Hingorani4, Shunqi Yan3, Bahram Kiani5 and Litain Yeh3, 1Arthrosi Therapeutics, Inc., Chapel Hill, NC, 2Chung Shan Medical University, Taichung, Taiwan (Republic of China), 3Arthrosi Therapeutics, Inc., San Diego, CA, 4Vanguard Healthsciences, Inc., San Diego, CA, 5Wake Forest University School of Medicine, Winston-Salem, NC

    Background/Purpose: AR882 is a novel and selective URAT1 inhibitor currently in clinical stage development for the treatment of gout and tophaceous gout and has demonstrated…
  • Abstract Number: 0939 • ACR Convergence 2023

    HRCT-derived Delta Radiomic Features Classify Response to Anti-Fibrotic Treatment in Experimental and Human Fibrosing Interstitial Lung Disease

    David Lauer1, Luca Romano Kolly1, Hubert Gabrys2, Matthias Brunner1, Malgorzata Anna Maciukiewicz1, Thomas Frauenfelder3, Stephanie Tanadini-Lang2, Anne-Christine Uldry4, Manfred Heller4, Kerstin Klein5, Oliver Distler6, Janine Gote-Schniering1 and Britta Maurer7, 1University Hospital Bern, Bern, Switzerland, 2University Hospital Zurich, Zurich, Switzerland, 3Dept of Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 4University of Bern, Bern, Switzerland, 5Department of Rheumatology and Immunology, University Hospital Bern, Bern, Switzerland, 6Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland, 7University Hospital Bern, University Bern, Bern, Switzerland

    Background/Purpose: Quantification of response to anti-fibrotic drugs in patients with fibrosing interstitial lung disease (ILD) relies on repeated pulmonary function tests (PFT) and visual evaluation…
  • Abstract Number: 1286 • ACR Convergence 2023

    Impact of Body Mass Index (BMI) on Upper versus Lower Extremity Joints Assessed Using Clinical and Musculoskeletal Ultrasound Measures in Rheumatoid Arthritis Patients

    Nicolette Morris1, Elena Saab2, Lucia Chen1, Jenny Brook1, Gurjit S Kaeley3, David Elashoff1 and Veena Ranganath1, 1David Geffen School of Medicine, UCLA, Los Angeles, CA, 2Wake Forest University School of Medicine, Los Angeles, CA, 3University of Florida College of Medicine – Jacksonville, Ponte Vedra Beach, FL

    Background/Purpose: Tender and swollen joints counts may be differentially affected in rheumatoid arthritis (RA) patients with obesity. A prior study demonstrated an association between increased…
  • Abstract Number: 1716 • ACR Convergence 2023

    High-Throughput Semi-Automated Micro-CT Analysis Identifies the Cuboid Bone as a Sex-Dependent Biomarker of Inflammatory-Erosive Arthritis in TNF-Tg Mice

    H. Mark Kenney1, Kiana Chen2, Lindsay Schnur3, Jeffrey Fox3, Ronald Wood3, Lianping Xing4, Christopher T Ritchlin5, Homaira Rahimi6, Edward Schwarz6 and Hani Awad3, 1University of Rochester School of Medicine and Dentistry, Henrietta, NY, 2University of Rochester School of Medicine and Dentistry, Rochester, NY, 3University of Rochester Medical Center, Rochester, NY, 4University of Rochester Medical Center, Webster, NY, 5University of Rochester Medical School, Allergy, Immunology & Rheumatology Division, Canandaigua, NY, 6University of Rochester, Rochester, NY

    Background/Purpose: Development of reliable disease activity biomarkers is critical for diagnostics, prognostics, and novel drug development. In the case of preclinical models of inflammatory-erosive arthritis,…
  • Abstract Number: 1959 • ACR Convergence 2023

    Quantitative Scoring of High Resolution Chest Computed Tomography (HRCT) Images in Myositis and Antisynthetase Syndrome Related Interstitial Lung Disease in Comparison to Scleroderma Related Interstitial Lung Disease

    Sangmee Bae1, Fereidoun Abtin2, Grace Kim3, Siamak Moghadam-Kia4, Chester V. Oddis5, Lila Pourzand2, Didem Saygin5, Daniel Sullivan6, Koichi Yamaguchi7, Donald Tashkin3, Christina Charles-Schoeman8, Jonathan Goldin3 and Rohit Aggarwal5, 1UCLA Rheumatology, Los Angeles, CA, 2UCLA Radiological Sciences, Los Angeles, CA, 3University of California Los Angeles, Los Angeles, CA, 4University of Pittsburgh Medical Center, Pittsburgh, PA, 5University of Pittsburgh, Pittsburgh, PA, 6UCLA Pulmonology, Pittsburgh, PA, 7University of Pittsburgh Medical Center Rheumatology, Pittsburgh, PA, 8UCLA Medical Center, Santa Monica, CA

    Background/Purpose: High resolution computed tomography (HRCT) of the chest has become an important modality in the evaluation of interstitial lung disease (ILD). A quantitative CT…
  • Abstract Number: 2525 • ACR Convergence 2023

    Comparing Patellar Tendon Characteristics Between Adults with and Without Knee Pain

    Samantha Price1, Karin Silbernagel2, David Felson3, Joshua Stefanik4 and Patrick Corrigan1, 1Saint Louis University, St. Louis, MO, 2University of Delaware, Avondale, PA, 3Boston University, Boston, MA, 4Northeastern University, Boston, MA

    Background/Purpose: Knee pain is one of the most common types of joint pain leading to disability, limited physical activity, and reduced quality of life. While…
  • Abstract Number: 0167 • ACR Convergence 2023

    Healthcare Resource Utilization Associated with Tumor-Induced Osteomalacia: Review of Patient Histories Prior to Entry in Clinical Trial UX023T-CL201

    Suzanne Jan de Beur1, Thomas Carpenter2, Kathryn Dahir3, Erik Imel4, María Belén Zanchetta5, Angela Williams6, Zhiyi Li7, Matthew Sharp6 and Ben Johnson6, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Yale School of Medicine, New Haven, CT, 3Vanderbilt University Medical Center, Nashville, TN, 4Indiana University School of Medicine, Indianapolis, IN, 5Universidad del Salvador, Buenos Aires, Argentina, 6Kyowa Kirin International, Marlow, United Kingdom, 7Kyowa Kirin North America, Bedminster, NJ

    Background/Purpose: Tumor-induced osteomalacia (TIO) is an ultra-rare paraneoplastic disorder, characterized by renal phosphate wasting due to increased production of fibroblast growth factor 23 (FGF23). Chronic…
  • Abstract Number: 1033 • ACR Convergence 2023

    The Detection of Subclinical Joint Inflammation by Thermal and Ultrasound Imaging at the Metacarpophalangeal Joints in Patients with Rheumatoid Arthritis

    York Kiat Tan1 and Gek Hsiang Lim2, 1Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore, 2Health Services Research Unit, Singapore General Hospital, Singapore, Singapore

    Background/Purpose: While magnetic resonance imaging and ultrasound (US) imaging have been shown to be useful in the detection of subclinical joint inflammation in rheumatoid arthritis…
  • Abstract Number: 1287 • ACR Convergence 2023

    Impact of Body Mass Index (BMI) on Rheumatoid Arthritis Disease Activity and Musculoskeletal Ultrasound Measures

    Nicolette Morris1, Elena Saab2, Lucia Chen1, Jenny Brook1, Gurjit S Kaeley3, David Elashoff1 and Veena Ranganath1, 1David Geffen School of Medicine, UCLA, Los Angeles, CA, 2Wake Forest University School of Medicine, Los Angeles, CA, 3University of Florida College of Medicine – Jacksonville, Ponte Vedra Beach, FL

    Background/Purpose: Rheumatoid arthritis (RA) patients with obesity are less likely to respond to therapy and achieve remission. Obesity is a known driver of inflammatory processes…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 43
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology